Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Molecular IVD Tests See Faster Revenue Growth Than Standard IVD: Report

NEW YORK, NY -- (Marketwire) -- 02/01/13 -- Tests aimed a molecular target for use in clinical decision-making will produce much faster revenue growth than traditional IVD tests, according to Kalorama Information. Kalorama Information said tests are a 5.2 billion dollar market and will grow 8% each year to 7.6 billion by 2017. That's four times as fast as revenue growth in standard chemistry tests and twice as fast as immunoassay markets, according to the company's IVD market research database. The finding was made in its recent report, "The World Market for Molecular Diagnostics, 5th Edition."

The continued discovery of genetic markers with proven clinical utility and the increasing adoption of genetic based diagnostic tests are driving usage. The most attractive growth areas are molecular tests for histological analyses, women's health, infectious diseases, organ transplant testing and oncology. New tests are being launched all the time. Many molecular tests are CE Marked and FDA-cleared and many more are in development.

"These are exciting times for molecular diagnostics," said Shara Rosen, Kalorama Information's lead analyst and author of the report. "It represents one of the fastest growing segments of the diagnostics market. It has emerged fully from research into clinical practice."

Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. There are many new tests, technologies and companies. Competition is becoming very intense. The competition, according to Kalorama is not only between companies and products but also between technologies. There are RNA, DNA and protein patterns, sequencing, tissue arrays, circulating cells and cell-free nucleic acids. The ensemble of these elements create a market for a wide variety of options -- multiplexed, rapid, user friendly test platforms such as microarrays, liquid bead arrays and other user-friendly technologies. But the report is careful to note that not all new technologies can be a success -- with so many technologies and platforms to choose from, some of the valuable but less aggressively promoted products may fall by the wayside. Also, molecular tests, especially for inherited diseases and some FISH analyses are extremely complex. The tests provide raw data, the interpretation of which sometimes baffle even the most experienced molecular biologists.

"Optimism for the future benefits to modern medicine is tempered by the fact that the big payoff is still a way off," said Rosen. "Finding the genes that can raise the risk of an illness doesn't mean you can prevent the disease. And developing a treatment for it can take years."

One of the major challenges facing molecular testing is getting stakeholders including payers, physicians, researchers and regulators to work together to close the gap between research and clinical applicability. Physician education is another area that could advance the use of molecular assays. Still Rosen feels that the ensemble of these elements create a dynamic, energetic and fast-moving environment for new tests and companies. This chapter provides an overview of the market forces and their impact on molecular tests.

The Report, "The World Market for Molecular Diagnostics, 5th Edition" presents further growth rates for sub markets within molecular testing, regional breakouts of revenue figures, important strategic conclusions for companies in the market, profiles of companies in the market. The report can be found at http://www.kaloramainformation.com/Molecular-Diagnostics-Edition-7295219/

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Add to Digg Bookmark with del.icio.us Add to Newsvine

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Cloud Developer Stories
The BPM world is going through some evolution or changes where traditional business process management solutions really have nowhere to go in terms of development of the road map. In this demo at 15th Cloud Expo, Kyle Hansen, Director of Professional Services at AgilePoint, shows...
SYS-CON Events announced today Isomorphic Software, the global leader in high-end, web-based business applications, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Isomorphic Software is ...

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and deli...

"BSQUARE is in the business of selling software solutions for smart connected devices. It's obvious that IoT has moved from being a technology to being a fundamental part of business, and in the last 18 months people have said let's figure out how to do it and let's put some focu...
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE